Results 241 to 250 of about 80,266 (330)

Repurposing pacritinib to target MYD88-mutated Waldenström macroglobulinaemia. [PDF]

open access: yesBr J Haematol
Liu S   +15 more
europepmc   +1 more source

Clinical relevant Bruton's X-linked tyrosine kinase deficiency in a female with extreme X-chromosome inactivation. [PDF]

open access: yesAllergy Asthma Clin Immunol
NoorSaeed SM   +4 more
europepmc   +1 more source

Data from First-in-Human Study of the Reversible BTK Inhibitor Nemtabrutinib in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia and B-Cell Non–Hodgkin Lymphoma

open access: gold
Jennifer A. Woyach   +15 more
openalex   +1 more source

A potent seven-membered cyclic BTK (Bruton's tyrosine Kinase) chiral inhibitor conceived by structure-based drug design to lock its bioactive conformation

open access: green, 2019
Francisco Lopez‐Tapia   +5 more
openalex   +1 more source

Successful Zanubrutinib Monotherapy in a Rare CNS Presentation of Relapsed CLL. [PDF]

open access: yesCase Rep Hematol
Kunta V   +3 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy